Anas Ali Alhur
Department of Health Informatics, College of Public Health and Health Informatics, University of Hai, College of Public Health and Health Informatics, Saudi ArabiaPublications
-
Review
Digital solutions for personalized medicine: The future of pharmacogenomics
Author(s): Anas Ali Alhur*, Sarah Almutairi, Ahad Al-Shardi, Gilan Alnasser, Mohammed Alhanfoosh, Fahad Mashyakhi, Hanan Abdulbary, Shahad Khawaji and Lama Altuwijri
Pharmacogenomics, the study of how genetic variations influence individual drug responses, represents a cornerstone of personalized medicine. Recent advancements in digital health technologies have significantly enhanced the feasibility of integrating pharmacogenomics into clinical practice. Tools such as Artificial Intelligence (AI), big data analytics, and blockchain have transformed the ways genetic data are analyzed, stored, and applied in healthcare. These innovations enable the delivery of precise drug therapies, mitigate adverse drug reactions, and enhance overall patient outcomes. Despite the substantial promise, challenges related to data privacy, interoperability, cost, and equitable access persist. This paper explores the role of digital technologies in advancing pharmacogenomics, highlighting their transformative potential and offering strategies to address existing barrie.. Read More»
DOI: 10.5281/zenodo.200121